ReviewClinical and experimental gastroenterology2024

Second-Line Treatment of Pancreatic Adenocarcinoma: Shedding Light on New Opportunities and Key Talking Points from Clinical Trials.

Robin Imperial et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.